Controlled clinical trials in nephrology


Cite item

Full Text

Abstract

Peculiarities of controlled clinical trials in nephrology are discussed

References

  1. Guyatt G., EBM Working Group. Evidence based medicine. A new approach to teaching the practice of medicine. J.A.M.A. 1992; 268: 2420-2425
  2. Strippoli G.F., Craig J.C., Schena F.P. The number, quality and coverage of randomized controlled trials in nephrology. J. Am. Soc. Nephrol. 2004; 15(2): 411 - 419
  3. Coresh J., Selvin E., Stevens L.A. et al. Prevalence of chronic kidney disease in the United States. J.A.M.A. 2007; 298(17): 2038-2047
  4. Мухин Н.А., Моисеев В.С. Кардиоренальные соотношения и риск сердечно-сосудистых заболеваний. Вестник РАМН 2003; 11: 50 - 55
  5. Смирнов А.В., Добронравов В.А., Каюков И.Г. Кардио-ренальный континуум: патогенетические основы превентивной нефрологии. Нефрология. 2005; 9(3): 7 - 12
  6. Ruggenenti P., Chiurchiu C., Abbate M. et al. Rituximab for idiopathic membranous nephropathy: who can benefit? Clin. J. Am. Soc. Nephrol. 2006; 1(4): 738-748
  7. Ruggenenti P., Cravedi P., Sghirlanzoni M.C. et al. Effects of rituximab on morphofunctional abnormalities of membranous nephropathy. Clin. J. Am. Soc. Nephrol. 2008; 3(6): 1652-1659
  8. Postma M.J., de Zeeuw D. The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitus. Nephrol. Dial. Transplant. 2009; 24(10): 2975-2983
  9. Hennig K., Woller P., Knoll P. Clinical experiences with 99m technetium-iron complex for renal scintigraphy - a comparison with mercury preparations. Fortschr. Geb. Rontgenstr. Nuklearmed. 1968; 109(3): 366-374
  10. Sharpstone P., Ogg C.S., Cameron J.S. Nephrotic syndrome due to primary renal disease in adults: II. A controlled trial of prednisolone and azathioprine. Br. Med. J. 1969; 2(5656): 535-539
  11. Valkenburg H.A., Haverkorn M.J., Goslings W.R. et al. Streptococcal pharyngitis in the general population. II. The attack rate of rheumatic fever and acute glomerulonephritis in patients. J. Infect. Dis. 1971; 124(4): 348-358
  12. Ponticelli C., Zucchelli P., Imbasciati E. et al. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranus nephropathy. N. Engl. J. Med. 1984; 310: 946-950
  13. Ponticelli C., Zucchelli P., Passerini P., Cesana B. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group. N. Engl. J. Med. 1992; 327: 599-603
  14. Ponticelli C., Zucchelli P., Passerini P. et al. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int. 1995; 48: 1600 - 1608
  15. Maschio G., Alberti D., Janin G. et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N. Engl. J. Med. 1996; 334(15): 939-945.
  16. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet. 1997; 349(9069): 1857-1863
  17. Brenner B.M., Cooper M.E., de Zeeuw D. et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 2001; 345(12): 861-869
  18. Lewis E.J., Hunsicker L.G., Clarke W.R. et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N. Engl. J. Med. 2001; 345: 851 - 860
  19. Adogoa L.Y., Appel L., Bakris G.L. et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis. JAMA 2001; 285: 2719 - 2728
  20. Бикбов Б.Т., Томилина Н.А. Состояние заместительной терапии с хронической почечной недостаточностью в Российской Федерации в 1998 - 2008 гг (отчет по данным Российского регистра заместительной почечной терапии). Нефрология и диализ 2009; 11(3): 141 - 149

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies